ROCHE HOLDING LTD
CIK 889131 · last filed 2023-01-26
ROCHE HOLDING LTD is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $283.5K of JSPRW on Jan 26, 2023. Across all open-market trades the lifetime net is −$283.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.9M across reported positions. The firm reports its address in Basel. 40 SEC filings were submitted jointly with ILLUMINA, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
JSPRW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GRENZACHERSTRASSE 124
BASEL CH-4070
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPRW) Delisted | 10%+ Owner | 4,549,606 | $0.00 | $910 | -$283.5K | 1 | 2023-01-26 |
| TRDA | 10%+ Owner | 2,495,385 | $4.75 | $11.85M | $0 | 1 | 2021-11-04 |
| Allakos Inc. (ALLK) Delisted | 10%+ Owner | 4,610,723 | $0.33 | $1.52M | $0 | 1 | 2018-07-23 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-26 | Jasper Therapeutics, Inc. (JSPRW) Delisted | Sell (S) | −150,000 | -$283.5K | EDGAR |
| 2021-11-04 | TRDA | Conv (C) | +5,627,050 | $0 | EDGAR |
| 2018-08-02 | — | Buy (P) | +48,663,081 | $6.67B | |
| 2018-07-23 | Allakos Inc. (ALLK) Delisted | Conv (C) | +9,221,446 | $0 | EDGAR |
| 2007-07-06 | — | Buy (P) | +2,000 | $21.5K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.